首页 | 本学科首页   官方微博 | 高级检索  
     


PROLACTIN AND GROWTH HORMONE DYNAMICS IN EPILEPTIC PATIENTS RECEIVING PHENYTOIN
Authors:R. D. C. ELWES  C. DELLAPORTAS  E. H. REYNOLDS  W. ROBINSON  W. R. BUTT  D. R. LONDON
Affiliation:University Department of Neurology, Institute of Psychiatry and Kings College Hospital Medical School, London, and the Women's Hospital and Queen Elizabeth Hospital, Birmingham UK
Abstract:Resting growth hormone and prolactin levels and dynamic responses to bromocriptine and metoclopramide have been measured in epileptic patients before treatment, and compared with a matched group taking phenytoin alone. Mean resting levels of prolactin were higher in patients taking phenytoin (untreated patients 204 mU/l, phenytoin treated patients 302 mU/l), but dynamic responses to metoclopramide and bromocriptine were unaffected. Mean resting levels of growth hormone were also higher in patients taking phenytoin (untreated patients 1.4 mU/l, phenytoin treated patients 6.0 mU/l) and paradoxical suppression was seen following bromocriptine. Phenytoin is unlikely to have any major action on the D2 receptor present on the lactotroph. The abnormalities in growth hormone may explain the well recognized effects of phenytoin on connective tissue.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号